3097674

Hompes PG

1986

The additional use of buserelin in HMG-HCG ovulation induction in PCO: a double blind controlled study.

3097675

Fleming R

1986

Induction of ovulation in polycystic ovarian disease.

3098314

Brawer JR

1986

Development of the polycystic ovarian condition (PCO) in the estradiol valerate-treated rat.

3098455

Dewis P

1986

Does testosterone affect the normal menstrual cycle?

3100704

Chikazawa K

1986

[Follicular development in pregnancy and the polycystic ovarian syndrome].

3104389

Calogero AE

1987

Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.

3104400

Ben-Nun I

1986

Management of gonadotrophin-induced cycles characterized by a significant discrepancy between oestrogen levels and dominant follicle size.

3106251

Lithell H

1987

Metabolic profile in obese women with the polycystic ovary syndrome.

3107162

Ota H

1987

Formation of polycystic ovary in mature rats by the long-term administration of human chorionic gonadotropin.

3109365

Brook CG

1987

Pulsatility of reproductive hormones: applications to the understanding of puberty and to the treatment of infertility.

3109366

Fraser HM

1987

Clinical applications of LHRH analogues.

3109964

Jansen RP

1987

Pulsatile intravenous gonadotropin-releasing hormone for ovulation-induction in infertile women. II. Analysis of follicular and luteal phase responses.

3111126

H?mori M

1987

[Relation between hyperprolactinemia and polycystic ovary syndrome].

3111127

Seifert B

1987

[Retrograde vascular catheterization as a differential diagnostic method of studying androgenization in the female].

3111899

Kuroda G

1987

[Ovulation induction with pulsatile gonadotropin-releasing hormone and continuous human menopausal gonadotropin in polycystic ovarian disease].

3113503

Simard M

1987

An intractable, ovary-independent impairment in hypothalamo-pituitary function in the estradiol-valerate-induced polycystic ovarian condition in the rat.

3113505

Jones HM

1987

Systematic studies invalidate the neonatally androgenized rat as a model for polycystic ovary disease.

3113653

Armitage M

1987

Successful treatment of infertility due to polycystic ovary disease using a combination of luteinising hormone releasing hormone agonist and low dosage menotrophin.

3116031

Steingold K

1987

Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease.

3116378

Molinatti GM

1987

[Polycystic ovary syndrome or Stein-Leventhal syndrome: findings and prospectives].

3116379

Sciarra F

1987

[Etiopathogenesis of the polycystic ovary syndrome].

3116380

Massobrio M

1987

[Neuroendocrine regulation of the secretion of gonadotropins in the polycystic ovary syndrome].

3116381

Flamigni C

1987

[Micropolycystic ovary syndrome: therapy of anovulation].

3116382

Ermini M

1987

[Selection criteria for drug therapy in patients with the polycystic ovary syndrome not wishing pregnancy].

3116528

Tudose TI

1987

[Effect of the antiserotoninergic preparation cyproheptadine on the levels of luteinizing and follicle-stimulating hormones and testosterone in patients with polycystic ovaries].

3117092

Gj?nnaess H

1987

Endocrine effects of ovarian electrocautery in patients with polycystic ovarian disease.

3117444

Polson DW

1987

Bromocriptine treatment of women with clomiphene-resistant polycystic ovary syndrome.

3117445

Polson DW

1987

Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome.

3117528

Haney AF

1987

Endocrine and anatomical correlations in human ovarian pathology.

3117832

Rosen GF

1987

Further evidence against dopamine deficiency as the cause of inappropriate gonadotropin secretion in patients with polycystic ovary syndrome.

3117873

Emperaire JC

1987

[Contribution of human menopausal gonadotropins purified as to their FSH content in anovulatory sterility presenting a difficult treatment problem].

3119370

Stuckey BG

1987

Continuous gonadotropin-releasing hormone for ovulation induction in polycystic ovarian disease.

3119371

Lanzone A

1987

Induction of ovulation by intermittent intravenous purified follicle-stimulating hormone in polycystic ovarian disease.

3119650

Blankstein J

1987

Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease.

3119655

Lanzone A

1987

Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease.

3119696

Prelevi? GM

1987

Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.

3120208

Stillman RJ

1987

Women's reproductive health: recent advances in therapies.

3121397

Wajchenberg BL

1988

The source(s) of estrogen production in hirsute women with polycystic ovarian disease as determined by simultaneous adrenal and ovarian venous catheterization.

3121398

Blake RE

1988

Dexamethasone suppresses sex-hormone binding globulin.

3123281

Radwanska E

1988

Successful use of gonadotropin-releasing hormone agonist leuprolide for in vitro fertilization in a patient with polycystic ovarian disease and infertility unresponsive to standard treatment.

3123511

Filicori M

1988

Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.

3123581

Nakamura Y

1987

[Ovulation induction with a combination of LHRH analogue and hMG pulsatile subcutaneous administration in PCO patients].

3125210

Lopez-Lopez E

1987

Response to clomiphene citrate in the polycystic ovarian syndrome according to different LH/FSH ratios.

3126215

Buckler HM

1988

Serum inhibin levels in polycystic ovary syndrome: basal levels and response to luteinizing hormone-releasing hormone agonist and exogenous gonadotropin administration.

3129057

Brook CG

1988

Polycystic ovaries in childhood.

3129451

Polson DW

1988

Serum 11 beta-hydroxyandrostenedione as an indicator of the source of excess androgen production in women with polycystic ovaries.

3130977

Traub AI

1987

Pure FSH induces ovulation in polycystic ovary syndrome despite rising androgen levels.

3131159

Ory SJ

1988

Pulsatile luteinizing hormone-releasing hormone therapy in women with polycystic ovarian syndrome.

3131386

Homburg R

1988

Improved treatment for anovulation in polycystic ovarian disease utilizing the effect of progesterone on the inappropriate gonadotrophin release and clomiphene response.

3131387

Salat-Baroux J

1988

Results of IVF in the treatment of polycystic ovary disease.

3132413

Birkh?user MH

1988

[Induction of follicle maturation with pure FSH in polycystic ovary syndrome].

3134388

Buckler HM

1988

Vaginal progesterone administration before ovulation induction with exogenous gonadotropins in polycystic ovarian syndrome.

3134391

Gompel A

1988

Induction of ovulation with pulsatile GnRH in hypothalamic amenorrhoea.

3134396

Franks S

1988

Mechanism and management of ovulatory failure in women with polycystic ovary syndrome.

3134397

Salat-Baroux J

1988

Comparison between long and short protocols of LHRH agonist in the treatment of polycystic ovary disease by in-vitro fertilization.

3134779

Martorana A

1987

Dexamethasone suppression test in hirsute women.

3135179

Kuroda G

1988

Continuous subcutaneous infusion of human menopausal gonadotropin in anovulatory women with decreased FSH/LH ratio and androgen excess.

3136040

Huang HJ

1988

[Effects of bromocriptine on endocrine environment in the polycystic ovary syndrome].

3136067

Franks S

1987

Use of LHRH agonists in the treatment of anovulation in women with polycystic ovary syndrome.

3136650

Fleming R

1988

Combined gonadotropin-releasing hormone analog and exogenous gonadotropins for ovulation induction in infertile women: efficacy related to ovarian function assessment.

3137253

Prelevi? GM

1988

Metoclopramide effect on serum prolactin LH and FSH in patients with polycystic ovary syndrome.

3138052

Faure N

1987

Ovarian suppression in polycystic ovarian disease during 6 month administration of a luteinizing hormone-releasing hormone (LH-RH) agonist.

3138869

Fleming R

1988

The use of GnRH analogues in combination with exogenous gonadotropins in infertile women.

3139335

Venturoli S

1988

Episodic pulsatile secretion of FSH, LH, prolactin, oestradiol, oestrone, and LH circadian variations in polycystic ovary syndrome.

3139468

Belaisch-Allart J

1988

Selective oocyte retrieval: a new approach to ovarian hyperstimulation.

3140076

Struzziero E

1988

[Gonadotropin treatment of anovulation in polycystic ovary. Clinical results].

3140583

Hull MG

1987

Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies.

3140589

Burger CW

1988

Pituitary response during pulsatile luteinizing hormone-releasing hormone ovulation--induction in patients with clomiphene citrate-resistant polycystic ovary-like disease.

3140591

Homburg R

1988

Synergism of pulsatile LHRH therapy with oral clomiphene treatment.

3140593

Filicori M

1988

Physiology and pathophysiology of pulsatile gonadotropin secretion.

3142595

Homburg R

1988

Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome.

3142597

Sagle M

1988

Recurrent early miscarriage and polycystic ovaries.

3143565

Adashi EY

1988

Hypothalamic-pituitary dysfunction in polycystic ovarian disease.

3143566

Blankstein J

1988

Induction of ovulation in the patient with polycystic ovarian disease.

3143567

Mahajan DK

1988

Steroidogenesis in human polycystic ovary.

3143568

Loy R

1988

Evaluation and therapy of polycystic ovarian syndrome.

3145187

Minakami H

1988

Prolactin release in polycystic ovarian syndrome.

3145220

Kimura K

1988

[A longitudinal study on the prognosis of ovulatory disturbance in teenage patients with high LH and normal FSH serum levels].

3145317

Utsunomiya T

1988

[The clinical and hormonal effects of laparoscopic multiple punch resection (MPR) of the ovary in polycystic ovary syndrome].

3147005

Fowler CJ

1988

Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome?

3147583

Venturini PL

1988

Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease: a new approach to induction of ovulation.

3148269

Szil?gyi A

1988

Increased prolactin response to TRH in polycystic ovary syndrome with low basal prolactin values.

3148503

Rosen A

1988

[The incidence of polycystic ovaries as a cause of sterility].

3150824

Nakamura Y

1988

Treatment of polycystic ovarian disease by inducing ovulation with pulsatile subcutaneous administration of human menopausal gonadotrophin associated with luteinizing hormone-releasing hormone analogue.

3150825

Faure N

1988

Acute pituitary-ovarian response during chronic luteinizing hormone-releasing hormone agonist administration in polycystic ovarian syndrome.

3150888

Padova G

1988

Ovulation monitored by serum 17 beta-estradiol and ultrasound: differential ovarian response to human gonadotropins in various anovulatory states.

3155511

Serafini P

1985

Increased 5 alpha-reductase activity in idiopathic hirsutism.

3155830

Haning RV Jr

1985

Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.

3157285

Palaty?ski A

1985

[Ovulation induction in sterile females with the polycystic ovary syndrome].

3157301

Chihal HJ

1985

Polycystic ovary syndrome.

3158218

El'tsov-Strelkov VI

1985

[Diagnosis and treatment of patients with typical forms of polycystic ovaries].

3158219

Tsarikovskaia NG

1985

[Conservative treatment of patients in the initial stage of sclerocystic ovary syndrome].

3158220

Orlova VG

1985

[Diagnosis and treatment of patients with an atypical form of the polycystic ovary syndrome].

3158221

Zenkina NP

1985

[Effectiveness of various methods of treatment of sclerocystic ovary syndrome depending on clinico-pathogenetic variants].

3158355

Farookhi R

1985

Unilateral ovariectomy restores ovulatory cyclicity in rats with a polycystic ovarian condition.

3158552

Pittaway DE

1985

Spironolactone in combination drug therapy for unresponsive hirsutism.

3160211

Cullberg G

1985

Effects of a low-dose desogestrel-ethinylestradiol combination on hirsutism, androgens and sex hormone binding globulin in women with a polycystic ovary syndrome.

3160212

Cullberg G

1985

Lipid metabolic studies in women with a polycystic ovary syndrome during treatment with a low-dose desogestrel-ethinylestradiol combination.

3160468

Familiari G

1985

Morphological studies of polycystic mouse ovaries induced by dehydroepiandrosterone.

3161265

Cullberg G

1985

Pharmacodynamic studies on desogestrel administered alone and in combination with ethinylestradiol.